Summary: A post-hoc analysis of the phase 3 REST-ON trial demonstrated that Lumryz (sodium oxybate) improves narcolepsy symptoms, including wakefulness, cataplexy episodes, and daytime sleepiness, regardless of whether patients were also using alerting medications. Both … [Read more...]
Melatonin Deficiency Tied to Worsening ADHD Symptoms in Kids
Summary: A new study from Hamamatsu University School of Medicine and international collaborators has identified a link between melatonin secretion and the severity of ADHD symptoms in children. The research suggests that genetic traits reducing nighttime melatonin production … [Read more...]
Vibrotactile Sleep Patch Reduces Insomnia-Related Symptoms
Summary: A study to be presented at the Sleep Europe Congress in Seville, Spain, highlights the effectiveness of a non-pharmacological, vibrotactile trigger technology (VTT)-embedded sleep patch in improving sleep quality, duration, and reducing insomnia-related symptoms. The … [Read more...]
Internet-Based CBT for Depression Improves Insomnia Symptoms
Summary: A Hebrew College analyze, posted in Psychotherapy Study, examined the consequences of guided internet-dependent cognitive behavioral therapy (CBT) on depression and insomnia. The study involved 39 individuals who underwent a six-module CBT system addressing melancholy … [Read more...]
AXS-12 Reduces Narcolepsy Symptoms in Phase 3 Trial
Summary: In the SYMPHONY stage 3 trial, Axsome Therapeutics’ AXS-12 considerably lowered weekly cataplexy assaults and improved indications of narcolepsy, which include extreme daytime sleepiness, cognitive operate, and over-all ailment severity, when compared to placebo. The … [Read more...]
Self-Regulation Therapy Improves Long COVID Symptoms
A UCLA-led study suggests that some people with long COVID may be able to alleviate certain symptoms, such as sleep disturbance, by using short-term, self-regulating therapies. The small-scale study, published in the Journal of Psychosomatic Research, recruited a group of 20 long … [Read more...]